Dyne Therapeutics Inc
(NAS:DYN)
$
15.87
-7.18 (-31.15%)
Market Cap: 1.62 Bil
Enterprise Value: 916.21 Mil
PE Ratio: 0
PB Ratio: 2.29
GF Score: 36/100 Dyne Therapeutics Inc at Jefferies Healthcare Conference Transcript
Jun 08, 2023 / 06:00PM GMT
Release Date Price:
$13.46
(-5.74%)
Eun Yang
Jefferies & Company - Analyst
Good afternoon, everybody. This is Eun Yang, a biotech analyst with the Jefferies, based in New York. Next presenting company is Dyne Therapeutics. And this is going to be a fireside chat. Joining me from Dyne are Josh Brumm, President and CEO, and Wildon Farwell, CMO of the company. So, thank you for joining us.
Josh Brumm
Dyne Therapeutics, Inc. - President and CEO
Thank you, Eun.
Wildon Farwell
Dyne Therapeutics, Inc. - Chief Medical Officer
Thank you.
Eun Yang
Jefferies & Company - Analyst
So before we start the Q&A, Josh, would you give us a kind of a brief overview of what Dyne does?
Josh Brumm
Dyne Therapeutics, Inc. - President and CEO
Well, thanks. Thanks again for inviting us here to the conference, Eun and Jefferies. I'm making some forward-looking statements, so please refer to our SEC filings on that matter.
Look, Dyne has been for me, personally,
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot